Hydroxycarteolol

Hydroxycarteolol
Clinical data
Other names	8-Hydroxycarteolol
ATC code	None;
Identifiers
	IUPAC name 8-Hydroxy-5-{2-hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}-3,4-dihydro-2(1H)-quinolinone;
CAS Number	59826-22-1;
PubChem CID	124688;
ChemSpider	111020;
ChEBI	CHEBI:192312;
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).;
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C16H24N2O4
Molar mass	308.378 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C2Nc1c(O)ccc(OCC(O)CNC(C)(C)C)c1CC2;
	InChI InChI=1S/C16H24N2O4/c1-16(2,3)17-8-10(19)9-22-13-6-5-12(20)15-11(13)4-7-14(21)18-15/h5-6,10,17,19-20H,4,7-9H2,1-3H3,(H,18,21); Key:TVZJLAKRXHGVOK-UHFFFAOYSA-N;

Hydroxycarteolol is a beta blocker and metabolite of carteolol.^[1]^[2]

References

^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.